1) |
Toda K:Treatment of chronic widespread pain is similar to treatment of fibromyalgia
throughout the world.J Musculoskelet Pain 2010;18:317-318. |
2) |
戸田克広:線維筋痛症がわかる本.主婦の友社,2010. |
3) |
Nishishinya B,Urrutia G,Walitt B,et al:Amitriptyline in the treatment of fibromyalgia:a
systematic review of its efficacy.Rheumatology(Oxford) 2008;47:1741-1746. |
4) |
Heymann RE,Helfenstein M,Feldman D:A double-blind,randomized,controlled study
of amitriptyline,nortriptyline and placebo in patients with fibromyalgia.An analysis of
outcome measures.Clin Exp Rheumatol 2001;19:697-702. |
5) |
戸田克広:線維筋痛症と脳脊髄液減少症を合併した1例.広島医学 2006;59:460-463. |
6) |
Wysenbeek AJ,Mor F,Lurie Y,et al:Imipramine for the treatment of fibrositis:a
therapeutic trial.Ann Rheum Dis 1985;44:752-753. |
7) |
Bibolotti E,Borghi C,Pasculli E,et al:The management of fibrositis A double-blind
comparisonof maprotilline(Ludiomil),chlomipramine and placebo.Clinical Trials
Journal 1986;23:269-280. |
8) |
山下 真,芦原 睦:線維筋痛症に対するClomipramine点滴療法の適応と有効性.日本線維筋痛症学会第2回学術集会プログラム抄録集.2010;45. |
9) |
Häuser W,Petzke F,Sommer C:Comparative efficacy and harms of duloxetine,
milnacipran,and pregabalin in fibromyalgia syndrome.J Pain 2010;11:505-521. |
10) |
Patkar AA,Masand PS,Krulewicz S,et al:A randomized,controlled,trial of controlled
release paroxetine in fibromyalgia.Am J Med 2007;120:448-454. |
11) |
Pae CU,Masand PS,Marks DM,et al:History of early abuse as a predictor of treatment
response in patients with fibromyalgia:A post-hoc analysis of a 12-week,randomized,
double-blind,placebo-controlled trial of paroxetine controlled release.World J Biol
Psychiatry 2009;10(4 Pt 2):435-441. |
12) |
Morillas-Arques P,Rodriguez-Lopez CM,Molina-Barea R,et al:Trazodone for the
treatment of fibromyalgia:an open-label,12-week study.BMC Musculoskelet Disord
2010;11:204. |
13) |
Straube S,Derry S,Moore RA,et al:Pregabalin in fibromyalgia:meta-analysis of efficacy
and safety from company clinical trial reports.Rheumatology(Oxford) 2010;49:706-
715. |
14) |
Toda K:Comparison of efficacy between neurotropin and amitriptyline in fibromyalgia.
Abstracts of the12th world congress on pain 2008;PT181. |
15) |
Toda K:Efficacy of lafutidine for fibromyalgia.Abstracts of the13th world congress on
pain 2010;PW 380. |
16) |
Drewes AM,Andreasen A,Jennum P,et al:Zopiclone in the treatment of sleep
abnormalities in fibromyalgia.Scand J Rheumatol 1991;20:288-293. |
17) |
Gronblad M,Nykanen J,Konttinen Y,et al:Effect of zopiclone on sleep quality,morning
stiffness,widespread tenderness and pain and general discomfort in primary
fibromyalgia patients.A double-blind randomized trial.Clin Rheumatol 1993;12:186-
191. |
18) |
Moldofsky H,Lue FA,Mously C,et al:The effect of zolpidem in patients with
fibromyalgia:a dose ranging,double blind,placebo controlled,modified crossover
study.J Rheumatol 1996;23:529-533. |
19) |
Pramipexole ER vs Placebo in Fibromyalgia:http://www.clinicaltrials.gov/ct2/show/NCT00689052 2011年3月31日確認 |
20) |
Holman AJ:Ropinirole,open preliminary observations of a dopamine agonist for
refractory fibromyalgia.J Clin Rheumatol 2003;9:277-279. |
21) |
Holman AJ:Treatment of fibromyalgia with the dopamine agonist ropinirole:a 14-week
double-blind randomized controlled trial(RCT)with 14-week blinded extension.
Arthritis Rheum 2004;50:S698. |
22) |
Singh G:Recent considerations in nonsteroidal anti-inflammatory drug gastropathy.
Am J Med 1998;105:31S-38S. |
23) |
Rico-Villademoros F,Hidalgo J,Morillas-Arques P,et al:An open-label study of
levopromazine(methotrimeprazine)as an add-on therapy in fibromyalgia
management.Clin Exp Rheumatol 2009;27:S16-20. |
24) |
Ali A,Njike VY,Northrup V,et al:Intravenous Micronutrient Therapy(Myers' Cocktail)
for Fibromyalgia:A Placebo-Controlled Pilot Study.J Altern Complement Med 2009;
15:247-257. |
25) |
三木健司,行岡正雄,浦野房三,他:慢性疼痛疾患:線維筋痛症とリウマチ性脊椎関節炎の治療反応の相違.日本脊椎関節炎研究会誌2010;2:79-87. |
26) |
Bennett RM,Clark SC,Walczyk J:A randomized,double-blind,placebo-controlled
study of growth hormone in the treatment of fibromyalgia.Am J Med 1998;104:227-
231. |
27) |
Sorensen J,Bengtsson A,Backman E,et al:Pain analysis in patients with fibromyalgia.
Effects of intravenous morphine,lidocaine,and ketamine.Scand J Rheumatol 1995;
24:360-365. |
28) |
Guedj E,Cammilleri S,Colavolpe C,et al:Follow-up of pain processing recovery after
ketamine in hyperalgesic fibromyalgia patients using brain perfusion ECD-SPECT.Eur J
Nucl Med Mol Imaging 2007;34:2115-2119. |
29) |
Lee SS,Kim SH,Nah SS,et al:Smoking habits influence pain and functional and
psychiatric features in fibromyalgia.Joint Bone Spine 2010;Epub ahead of print. |
30) |
McNally JD,Matheson DA,Bakowsky VS.The epidemiology of self-reported
fibromyalgia in Canada.Chronic Dis Can 2006;27:9-16. |
31) |
Shapiro JR,Anderson DA,Danoff-Burg S:A pilot study of the effects of behavioral
weight loss treatment on fibromyalgia symptoms.J Psychosom Res 2005;59:275-
282. |
32) |
Ciappuccini R, Ansemant T, Maillefert JF, et al: Aspartame-induced fibromyalgia, an
unusual but curable cause of chronic pain. Clin Exp Rheumatol 2010; 28: S131-133. |
戸田克広
|